Minova Life Science

Minova life sciences - Pharmaceutical company

Minoliv UD 150/ 300 Tablets

COMPOSITION –  Ursodeoxycholic acid 150/300 mg 

Ursodeoxycholic acid

Drug Class: Gallstone dissolution agent

  • Ursodeoxycholic acid (UDCA) is a steroid bile acid approved for primary biliary cirrhosis, also widely used for the treatment of cholestatic liver diseases 
  • UDCA is reported to have “hepato-protective properties” and possesses multiple mechanisms of action.
  • Helps in reducing gallstone volume, number, or both, without apparent dose dependence, a safe & effective alternative to surgery in selected patients with gallstones.
  • Previously used for cholesterol gallstone dissolution, is currently considered the first choice therapy for many cholestatic syndromes.
  • Demonstrates the beneficial effect on liver function in children after successful surgery for biliary atresia.
  • Early UDCA therapy is beneficial for slowing down the progression of liver pathology.

Explore other products

Scroll to Top